Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids

Nature

Volumn 505, Issue 7482, 2014, Pages 218-222

  Cambier, C J ^a   Takaki, Kevin K ^a   Larson, Ryan P ^a,b   Hernandez, Rafael E ^c   Tobin, David M ^a   Urdahl, Kevin B ^a,b,c   Cosma, Christine L ^a   Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR 2; LIPID; MEMBRANE LIPID; PHENOLIC GLYCOLIPID; PHTHIOCEROL DIMYCOCEROSERATE LIPID; REACTIVE NITROGEN SPECIES; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

BACTERIUM; CYPRINID; LIPID; MEMBRANE; MOLECULAR ANALYSIS; RODENT; SIGNAL; SURVIVAL; TUBERCULOSIS; VIRULENCE;

ARTICLE; BACTERIAL VIRULENCE; IMMUNE EVASION; MACROPHAGE; MICROFLORA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; TUBERCULOSIS; ZEBRA FISH;

ANIMALS; FEMALE; GLYCOLIPIDS; IMMUNE EVASION; LIPIDS; MACROPHAGES; MEMBRANE LIPIDS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CCR2; TOLL-LIKE RECEPTORS; VIRULENCE; ZEBRAFISH;

CORYNEBACTERINEAE; DANIO RERIO; MUS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84892367843     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12799     Document Type: Article

References (39)

1. Philips, J. A. & Ernst, J. D. Tuberculosis pathogenesis and immunity. Annu. Rev. Pathol. 7, 353-384 (2012).
2. Onwueme, K. C., Vos, C. J., Zurita, J., Ferreras, J. A. & Quadri, L. E. N. The dimycocerosate ester polyketide virulence factors ofmycobacteria. Prog. Lipid Res. 44, 259-302 (2005).
3. Murry, J. P., Pandey, A. K., Sassetti, C. M. & Rubin, E. J. Phthiocerol dimycocerosate transport is required for resisting interferon-c-independentimmunity. J. Infect. Dis. 200, 774-782 (2009).
4. Flores-Villanueva, P. O. et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 202, 1649-1658 (2005).
5. Reed, M. B. et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-87 (2004).
6. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 (2007).
7. Weiser, J. N. The pneumococcus: why a commensal misbehaves. J. Mol. Med. 88, 97-102 (2010).
8. Yang, C.-T. et al. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe 12, 301-312 (2012).
9. Mayer-Barber, K. D. et al. Cutting edge: caspase-1 independent IL-1 production is critical for host resistance to Mycobacteriumtuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326-3330 (2010).
10. Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nature Rev. Immunol. 12, 352-366 (2012).
11. Rosenthal, S. & Tager, I. B. Prevalence of Gram-negative rods in the normal pharyngeal flora. Ann. Intern. Med. 83, 355-357 (1975).
12. Wertheim, H. F. L. et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5, 751-762 (2005).
13. Eddens, T. & Kolls, J. K. Host defenses against bacterial lower respiratory tract infection. Curr. Opin. Immunol. 24, 424-430 (2012).
14. de Mendonça-Lima, L. et al. The allele encoding the mycobacterial Erp protein affects lung disease in mice. Cell. Microbiol. 5, 65-73 (2003).
15. van der Vaart, M., van Soest, J. J., Spaink, H. P.&Meijer, A. H. Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system. Dis. Model. Mech. 6, 841-854 (2013).
16. Tobin, D. M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717-730 (2010).
17. Chan, J., Xing, Y., Magliozzo, R. S. & Bloom, B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175, 1111-1122 (1992).
18. Kröncke, K. D., Fehsel, K. & Kolb-Bachofen, V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113, 147-156 (1998).
19. Serbina, N. V., Jia, T.,Hohl, T. M.&Pamer, E. G.Monocyte-mediated defense against microbialpathogens. Annu. Rev. Immunol. 26, 421-452 (2008).
20. Antonelli, L. R. V. et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120, 1674-1682 (2010).
21. Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522-531 (2007).
22. Bates, J. H., Potts, W. E. & Lewis, M. Epidemiology of primary tuberculosis in an industrial school. N. Engl. J. Med. 272, 714-717 (1965).
23. Wells, W. F., Ratcliffe, H. L. & Grumb, C. On the mechanics of droplet nuclei infection; quantitative experimental air-borne tuberculosis in rabbits. Am. J. Hyg. 47, 11-28 (1948).
24. Sinsimer, D. et al. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect. Immun. 76, 3027-3036 (2008).
25. Scott, H. M. & Flynn, J. L. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70, 5946-5954 (2002).
26. Feng, W. X. et al. CCL222518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis. Int. J. Tuberc. Lung Dis. 16, 150-156 (2012).
27. Gagneux, S. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 2869-2873 (2006).
28. Charlson, E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184, 957-963 (2011).
29. von Bernuth, H., Picard, C., Puel, A. & Casanova, J.-L. Experimental and natural infections in MyD88-and IRAK-4-deficient mice and humans. Eur. J. Immunol. 42, 3126-3135 (2012).
30. Comas, I. et al.Out-of-Africa migrationandNeolithic coexpansion ofMycobacterium tuberculosis with modern humans. Nature Genet. 45, 1176-1182 (2013).
31. Cosma, C. L., Klein, K., Kim, R., Beery, D. & Ramakrishnan, L. Mycobacterium marinum Erp is a virulence determinant required for cell wall integrity and ntracellular survival. Infect. Immun. 74, 3125-3133 (2006).
32. Takaki, K.,Cosma, C. L., Troll, M. A.&Ramakrishnan, L.Anin vivo platformfor rapid high-throughput antitubercular drug discovery. Cell Rep. 2, 175-184 (2012).
33. Brannon, M. K. et al. Pseudomonas aeruginosa Type III secretion systeminteracts with phagocytes to modulate systemic infection of zebrafish embryos. Cell. Microbiol. 11, 755-768 (2009).
34. Yu, J. et al. Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacteriummarinum. Infect. Immun. 80, 1381-1389 (2012).
35. Takaki, K., Davis, J. M., Winglee, K. & Ramakrishnan, L. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nature Protocols 8, 1114-1124 (2013).
36. Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
37. Clay, H. et al. Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2, 29-39 (2007).
38. Lepiller, S. et al. Imaging of nitric oxide in a living vertebrate using a diaminofluorescein probe. Free Radic. Biol. Med. 43, 619-627 (2007).
39. Maruyama, I. N., Rakow, T. L. & Maruyama, H. I. cRACE: a simple method for identification of the 59 end of mRNAs. Nucleic Acids Res. 23, 3796-3797 (1995).